Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Delek Logistics Partners shows strong Q1 growth and stable cash flow, signaling buy potential with target price up to $80.71

Analyst Insights
02 May 2026
Seeking Alpha
View Source
Bullish
pluang ai news

Delek Logistics Partners, LP reported a 19% year-over-year revenue increase in Q1 2026 to $297.5 million, driven by strong midstream operations and higher third-party business. Despite facing cost pressures, the company maintains solid liquidity, effective debt management, and stable cash flows that support ongoing distributions. The stock has rebounded from a recent dip, and valuation models suggest further upside, with a target price range between $66.22 and $80.71. This resilience and robust fundamentals underpin a reiterated buy rating for investors looking for stable logistics sector exposure.

More News

IPG launches sustainable air pillow film with 50% recycled content for eco-friendly packaging.

IPG launches sustainable air pillow film with 50% recycled content for eco-friendly packaging.

Intertape Polymer Corp (IPG) has introduced a new PCR Air Pillow Film made with 50% recycled materials, including 35% post-consumer recycled content. This high-performance packaging film is designed to help companies meet sustainability goals without...

Others
Bullish
59 minutes ago
Global infant heart monitor market to reach $7.93B by 2035 with 10.85% CAGR, driven by tech advances and home care demand

Global infant heart monitor market to reach $7.93B by 2035 with 10.85% CAGR, driven by tech advances and home care demand

The global infant heart monitor market, valued at $2.83 billion in 2025, is projected to grow to $7.93 billion by 2035 at a CAGR of 10.85%. Growth is fueled by advances in wearable and wireless monitoring technologies, increased adoption of home care...

Market News
Bullish
2 hours ago
Europe approves TEPKINLY combo for relapsed follicular lymphoma, offering a chemo-free treatment option.

Europe approves TEPKINLY combo for relapsed follicular lymphoma, offering a chemo-free treatment option.

The European Commission has approved TEPKINLY (epcoritamab) combined with lenalidomide and rituximab for treating relapsed or refractory follicular lymphoma in adults. This marks the first bispecific antibody-based therapy authorized in Europe for se...

Market News
Bullish
3 hours ago
Halper Sadeh LLC probes fairness of major company sales for shareholders' benefit.

Halper Sadeh LLC probes fairness of major company sales for shareholders' benefit.

Halper Sadeh LLC is investigating whether shareholders of Arcosa, Bio-Techne, Iridium Communications, and LCI Industries are receiving fair deals in their companies' recent sales. The law firm suspects insiders may gain financial benefits not availab...

Market News
Bearish
3 hours ago
Class action deadlines approach for investors in BTGO, VIA, Z, and ADMA over alleged securities fraud.

Class action deadlines approach for investors in BTGO, VIA, Z, and ADMA over alleged securities fraud.

Law Offices of Howard G. Smith has announced upcoming deadlines for investors to file lead plaintiff motions in class action lawsuits against BitGo Holdings, Via Transportation, Zillow Group, and ADMA Biologics. These lawsuits allege that the compani...

Market News
Bearish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App